AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback